Boardroom Alpha
Start trial
Meeting calendar
GALT · Annual meeting · Wednesday, December 3, 2025

Galectin Therapeutics Inc

11 nominees · 5 ballot items.

Election of eleven directors; a non-binding advisory resolution to approve executive compensation; a non-binding advisory vote on the frequency of stockholder advisory votes on executive compensation; ratification of Cherry Bekaert LLP as independent auditors for the 2025 fiscal year; and other business as may come before the meeting.

Market cap
$285M
1Y TSR
+68.6%
Board grade
C+
Record date
Oct 7, 2025
Filing
DEF 14A
View proxy filingMeeting page
Meeting concluded · Dec 3, 2025

Follow how the vote landed and what changed on Galectin Therapeutics Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Start free trialView GALT
Proposals

On the ballot5

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of eleven nominees named in the accompanying proxy statement to hold office until the 2026 annual meeting of stockholders.

  2. 2

    Non-Binding Advisory Resolution to Approve Executive Compensation

    ManagementBoard: FOR

    Advisory vote to approve, on a nonbinding basis, the compensation of Galectin’s named executive officers as disclosed in the proxy statement accompanying the letter.

  3. 3

    Non-Binding Advisory Vote on the Frequency of Stockholder Approval of Executive Compensation

    ManagementBoard: FOR

    Advisory vote on how often Galectin will conduct stockholder advisory votes on executive compensation (every year, every two years, or every three years).

  4. 4

    Ratification of Appointment of Independent Auditors

    ManagementBoard: FOR

    Ratify Cherry Bekaert LLP as Galectin Therapeutics’ independent registered public accounting firm for the fiscal year ending December 31, 2025.

  5. 5

    Other Business

    Management

    To transact such other business as may properly come before the meeting or any adjournments.

Director elections

Nominees on the ballot11

Benjamin S. Carson, Sr., M.D.
Not independent
Tenure on this board
2.6 yrs
Also a director at
Horton D R Inc (DHI)Covenant Logistics Group Inc (CVLG)Sinclair Inc (SBGI)
Joel Lewis
Not independent
Tenure on this board
8.6 yrs
Marc Rubin, M.D.
Independent
Tenure on this board
14.3 yrs
Also a director at
Curis Inc (CRIS)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC3.0%1,966,542$5M
2OSAIC HOLDINGS, INC.1.7%1,112,670$3M
3MARSHALL WACE, LLP1.4%890,269$2M
4MILLENNIUM MANAGEMENT LLC1.2%798,434$2M
5Wealthspire Advisors, LLC1.1%721,788$2M
6BlackRock, Inc.1.0%676,501$2M
7SUSQUEHANNA INTERNATIONAL GROUP, LLP0.8%541,095$2M
8GEODE CAPITAL MANAGEMENT, LLC0.8%497,957$1M
9TWO SIGMA INVESTMENTS, LP0.7%467,063$1M
10COMMONWEALTH EQUITY SERVICES, LLC0.6%367,113$1M
Filings

Recent key filings

Periodic reports
Definitive proxies
Peers

Other Healthcare sector meetings6

Nearest market cap

Upcoming shareholder meetings at Galectin Therapeutics Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.

Trubridge IncTBRG
Special meeting·Jul 7, 2026·$393M
Cross Country Healthcare IncCCRN
Special meeting·Jul 16, 2026·$427M
Seer IncSEER
Annual meeting·Jul 28, 2026·$91M
Xoma Royalty CorpXOMA
Annual meeting·Jul 13, 2026·$533M
Achieve Life Sciences IncACHV
Annual meeting·Jul 2, 2026·$670M
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$734M
Reference

Frequently asked questions

When is the Galectin Therapeutics Inc 2025 annual meeting?
Galectin Therapeutics Inc (GALT) holds its 2025 annual shareholder meeting on Wednesday, December 3, 2025.
What is the record date for the Galectin Therapeutics Inc 2025 meeting?
The record date for the Galectin Therapeutics Inc 2025 meeting is Tuesday, October 7, 2025. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Galectin Therapeutics Inc's 2025 meeting?
The board is presenting 11 director nominees at the Galectin Therapeutics Inc 2025 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Galectin Therapeutics Inc 2025 meeting?
Shareholders will vote on 5 proposals at the Galectin Therapeutics Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Back to the meeting calendar
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer